E0 ConsensusPreliminaryPEM not requiredMeta-AnalysisPeer-reviewedReviewed
Standard · 3 min
Mindfulness-based therapies in the treatment of somatization disorders: a systematic review and meta-analysis.
Lakhan, Shaheen E, Schofield, Kerry L · PloS one · 2013 · DOI
Quick Summary
This review looked at 13 studies testing whether mindfulness-based therapy (a technique that teaches people to focus on the present moment without judgment) helps people with conditions like chronic fatigue syndrome, fibromyalgia, and irritable bowel syndrome. The researchers found that mindfulness therapy showed small to moderate benefits for reducing pain, symptom severity, depression, and anxiety, and for improving quality of life, though the overall evidence was limited.
Why It Matters
ME/CFS patients often experience comorbid anxiety and depression alongside physical symptoms, and this review suggests mindfulness-based approaches may provide benefit for symptom management. Understanding which psychological interventions have evidence-based support is important for developing comprehensive, person-centered treatment options for ME/CFS.
Observed Findings
Small to moderate reduction in pain severity (SMD = -0.21)
Small to moderate reduction in overall symptom severity (SMD = -0.40)
Small to moderate improvements in quality of life (SMD = 0.39)
Small to moderate reduction in depression (SMD = -0.23)
Minor reduction in anxiety that did not reach statistical significance (SMD = -0.20, p = 0.07)
Irriitable bowel syndrome showed the most consistent benefits across outcomes
Inferred Conclusions
Mindfulness-based therapies show preliminary promise for reducing pain and symptom severity in somatization disorders including ME/CFS.
Mindfulness-based stress reduction and cognitive therapy variants appear more effective than eclectic mindfulness approaches.
Quality of life improvements represent a meaningful benefit even with modest effect sizes.
Further rigorous research is needed to establish MBT efficacy more definitively.
Remaining Questions
How do mindfulness-based interventions compare to other validated psychological or rehabilitative therapies for ME/CFS specifically?
What This Study Does Not Prove
This meta-analysis does not demonstrate that mindfulness therapy is a primary treatment for ME/CFS or that it addresses underlying disease mechanisms. The small to moderate effect sizes and limited statistical power mean results should be interpreted cautiously, and the review does not establish causation or rule out placebo effects. Notably, the inclusion of somatization disorder framing may not accurately capture ME/CFS pathophysiology.
Tags
Symptom:Cognitive DysfunctionPainFatigue
Method Flag:PEM Not DefinedWeak Case DefinitionMixed CohortExploratory OnlySmall Sample
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.